94-1102. National Cancer Institute; Meeting of the Frederick Cancer Research and Development Center Advisory Committee  

  • [Federal Register Volume 59, Number 88 (Monday, May 9, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-1102]
    
    
    [[Page Unknown]]
    
    [Federal Register: May 9, 1994]
    
    
    -----------------------------------------------------------------------
    
    
    FEDERAL TRADE COMMISSION
     
    
    National Cancer Institute; Meeting of the Frederick Cancer 
    Research and Development Center Advisory Committee
    
        Pursuant to Public Law 92-463, notice is hereby given of the 
    meeting of the Frederick Cancer Research and Development Center 
    Advisory Committee, June 13-14, 1994, Building 549, Executive Board 
    Room, NCI Frederick Cancer Research and Development Center, Frederick, 
    Maryland.
        This meeting will be open to the public on June 13 from 8:30 a.m. 
    to approximately 10:30 a.m. to discuss administrative matters such as 
    future meetings, budget, and informational items related to the 
    operation of the NCI Frederick Cancer Research and Development Center. 
    Attendance by the public will be limited to space available.
        In accordance with the provisions set forth in sections 552b(c)(4) 
    and 552b(c)(6), title 5, U.S.C. and section 10(d) of Public Law 92-463, 
    the meeting will be closed to the public on June 13 from approximately 
    10:30 a.m. to recess and on June 14 from 8:30 a.m. to adjournment for 
    discussion of the previous site visit recommendations for the Chemistry 
    of Carcinogenesis Laboratory under contract with Advanced BioScience 
    Laboratories-Basic Research Program (ABL-BRP) and site visit review of 
    the ABL-BRP Mammalian Genetics Laboratory.
        These discussions could reveal confidential trade secrets or 
    commercial property such as patentable material and personal 
    information concerning individuals associated with the Contractor, the 
    disclosure of which would constitute a clearly unwarranted invasion of 
    personal privacy.
        Ms. Carole Frank, Committee Management Officer, National Cancer 
    Institute, Executive Plaza North, Room 630E, National Institutes of 
    Health, 9000 Rockville Pike, Bethesda, Maryland 20892-9906, Tel. (301) 
    496-5708, will provide a summary of the meeting and a roster of 
    committee members upon request.
        Dr. Cedric W. Long, Executive Secretary, Frederick Cancer Research 
    and Development Center Advisory Committee, National Cancer Institute 
    Frederick Cancer Research and Development Center, P.O. Box B, 
    Frederick, Maryland 21702-1201, Tel. (301) 846-1108, will furnish 
    substantive program information upon request.
        Individuals who plan to attend and need special assistance, such as 
    sign language interpretation or other reasonable accommodations, should 
    contact Dr. Cedric Long, Tel. (301) 846-1108 in advance of the meeting.
    
    (Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
    Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
    Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
    Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
    Cancer Research Manpower, 93.399, Cancer Control)
    
        Dated: May 3, 1994.
    Susan K. Feldman,
    Committee Management Officer, NIH.
    [FR Doc. 94-1102 Filed 5-6-94; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Published:
01/18/1994
Department:
Federal Trade Commission
Entry Type:
Uncategorized Document
Document Number:
94-1102
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: May 9, 1994